Welcome to our dedicated page for Airsculpt Technologies SEC filings (Ticker: AIRS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for AirSculpt Technologies, Inc. (NASDAQ: AIRS), a national provider of premium body contouring procedures. Through these documents, investors can review how the company reports its financial condition, operating results, governance changes and capital markets activity.
AirSculpt’s annual reports on Form 10‑K and quarterly reports on Form 10‑Q contain audited and interim financial statements, management’s discussion and analysis, detailed risk factors and information about its single operating segment focused on direct medical procedure services. These filings also discuss the company’s use of non-GAAP measures such as Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income and Adjusted Net Income per Share, along with reconciliations to GAAP metrics.
Current reports on Form 8‑K disclose material events, including quarterly earnings releases, updates to revenue and Adjusted EBITDA guidance, leadership and board changes, executive employment terms, resignations of officers, and capital structure developments. Recent 8‑K filings, for example, describe the appointment of a new Chief Financial Officer, the election of a Non-Executive Chairman of the Board, executive and board departures, and the announcement of quarterly results.
For those monitoring ownership and compensation, proxy materials and, where applicable, insider transaction reports on Form 4 can provide additional insight into equity awards, performance-based restricted stock units and other elements of the company’s equity incentive plans as referenced in its filings.
Stock Titan enhances this filings feed with AI-powered summaries that highlight key points from lengthy documents, helping readers quickly understand changes in guidance, capital structure, risk disclosures and governance arrangements. Filings are updated in near real time as they are posted to EDGAR, allowing investors, analysts and other stakeholders to follow AirSculpt’s regulatory reporting history and evaluate AIRS stock using primary source information.
Airsculpt Technologies, Inc. major shareholder Jorey Chernett reported an open-market purchase of 88,000 shares of Common Stock at a weighted average price of
Airsculpt Technologies, Inc. major holder Jorey Chernett bought additional shares of the company. On this Form 4, Chernett reported an open-market purchase of 45,600 shares of common stock at a weighted average price of about $2.00 per share, increasing his direct holdings to 6,398,211 shares.
Airsculpt Technologies, Inc. Schedule 13G/A shows that Jorey Chernett beneficially owned 6,781,811 shares of Common Stock as of the close of business on
The filing states voting and dispositive power are held solely by the Reporting Person for the listed shares and that some of the shares are underlying currently exercisable call options.
Airsculpt Technologies, Inc. disclosed that 10% owner Jorey Chernett bought a total of 110,000 shares of common stock in open-market purchases. He acquired 80,000 shares at a weighted-average price of $1.71 on March 3 and 30,000 shares at $1.87 on March 4. According to the filing, these were executed in multiple trades at prices ranging from $1.67 to $1.77 and from $1.86 to $1.88. Following these purchases, Chernett directly owns 6,352,611 Airsculpt shares.
Airsculpt Technologies, Inc. major shareholder Jorey Chernett filed an initial Form 3 showing existing holdings in the company. The filing lists direct ownership of call options covering 429,200 shares and 6,242,611 shares of common stock, both as of the reported date, reflecting more than 10% beneficial ownership.
Parian Ultreia reports a significant passive stake in Airsculpt Technologies, Inc. The firm reports beneficial ownership of 3,180,000 shares of AirSculpt Technologies, representing 5.09% of the class, with sole voting and dispositive power over all reported shares as of the event date.
The filer certifies the shares were not acquired and are not held to change or influence control of Airsculpt Technologies, but instead as a passive investment. No other persons or subsidiaries are reported as having beneficial ownership or group status in connection with this holding.
Airsculpt Technologies, Inc. (AIRS) received an amended beneficial ownership report from SW Investment Management LLC and Partners LP. The filing states that, as of the event date, each reporting person beneficially owns 0 shares of Airsculpt common stock, representing 0.0% of the class, based on 62,440,000 shares outstanding.
SW Investment Management LLC is described as the investment manager and general partner of Partners LP, but both entities report no sole or shared voting or dispositive power over any Airsculpt shares. The signatory certifies that any securities referenced were acquired and held in the ordinary course of business and not for the purpose of changing or influencing control of the company.
AirSculpt Technologies, Inc. CEO Yogesh Jashnani reported a tax-related share withholding tied to restricted stock vesting. On February 3, 2026, 55,098 shares of common stock vested from restricted stock units. The company withheld 24,217 shares, valued at $2.58 per share, to cover $62,484.48 of withholding taxes. After this transaction, Jashnani directly beneficially owned 496,759 shares of AirSculpt Technologies common stock.
Airsculpt Technologies, Inc. received an updated ownership report showing that individual investor Jorey Chernett beneficially owns 6,156,061 shares of its common stock, representing 9.86% of the outstanding class.
Chernett reports sole voting and dispositive power over all these shares and certifies they were not acquired to change or influence control of Airsculpt. The ownership level triggered this amended Schedule 13G filing based on an event dated January 30, 2026.
AirSculpt Technologies' Chief Financial Officer received new equity awards tied to service and performance. On January 24, 2026, the CFO was granted 147,059 restricted stock units (RSUs) and 147,059 performance stock units (PSUs) at a price of $0 per unit.
The RSUs vest in three equal annual installments starting January 24, 2027, contingent on continued employment. Each PSU represents a right to one share of common stock and will vest based on relative total shareholder return over a three-year period compared with the S&P Health Care Select Industry Index, with outcomes ranging from 0% to 200% of the target award.